These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 22565023)

  • 1. Targeted drug delivery to the peripheral nervous system using gene therapy.
    Wolfe D; Mata M; Fink DJ
    Neurosci Lett; 2012 Oct; 527(2):85-9. PubMed ID: 22565023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted delivery of growth factors by HSV-mediated gene transfer for peripheral neuropathy.
    Chattopadhyay M
    Curr Gene Ther; 2013 Oct; 13(5):315-21. PubMed ID: 24369058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene therapy for chronic pain.
    Glorioso JC; Mata M; Fink DJ
    Curr Opin Mol Ther; 2003 Oct; 5(5):483-8. PubMed ID: 14601516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene therapy for the treatment of sensory neuropathy.
    Mata M; Chattopadhyay M; Fink DJ
    Expert Opin Biol Ther; 2006 May; 6(5):499-507. PubMed ID: 16610979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene therapy for pain: results of a phase I clinical trial.
    Fink DJ; Wechuck J; Mata M; Glorioso JC; Goss J; Krisky D; Wolfe D
    Ann Neurol; 2011 Aug; 70(2):207-12. PubMed ID: 21796661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploiting the neurotherapeutic potential of peptides: targeted delivery using HSV vectors.
    Glorioso JC; Mata M; Fink DJ
    Expert Opin Biol Ther; 2003 Dec; 3(8):1233-9. PubMed ID: 14640949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene therapy of bladder pain with herpes simplex virus (HSV) vectors expressing preproenkephalin (PPE).
    Yoshimura N; Franks ME; Sasaki K; Goins WF; Goss J; Yokoyama T; Fraser MO; Seki S; Fink J; Glorioso J; de Groat WC; Chancellor MB
    Urology; 2001 Jun; 57(6 Suppl 1):116. PubMed ID: 11378092
    [No Abstract]   [Full Text] [Related]  

  • 8. HSV gene transfer in the treatment of chronic pain.
    Fink DJ; Mata M
    Sheng Li Xue Bao; 2008 Oct; 60(5):610-6. PubMed ID: 18958369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vector-mediated gene transfer to express inhibitory neurotransmitters in dorsal root ganglion reduces pain in a rodent model of lumbar radiculopathy.
    Lee JY; Fink DJ; Mata M
    Spine (Phila Pa 1976); 2006 Jun; 31(14):1555-8. PubMed ID: 16778687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted gene delivery to the nervous system using herpes simplex virus vectors.
    Mata M; Glorioso JC; Fink DJ
    Physiol Behav; 2002 Dec; 77(4-5):483-8. PubMed ID: 12526987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of HSV-mediated gene transfer for the treatment of chronic pain.
    Mata M; Glorioso J; Fink DJ
    Exp Neurol; 2003 Nov; 184 Suppl 1():S25-9. PubMed ID: 14597322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene Transfer of Glutamic Acid Decarboxylase 67 by Herpes Simplex Virus Vectors Suppresses Neuropathic Pain Induced by Human Immunodeficiency Virus gp120 Combined with ddC in Rats.
    Kanao M; Kanda H; Huang W; Liu S; Yi H; Candiotti KA; Lubarsky DA; Levitt RC; Hao S
    Anesth Analg; 2015 Jun; 120(6):1394-404. PubMed ID: 25851180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroprotective effect of herpes simplex virus-mediated gene transfer of erythropoietin in hyperglycemic dorsal root ganglion neurons.
    Chattopadhyay M; Walter C; Mata M; Fink DJ
    Brain; 2009 Apr; 132(Pt 4):879-88. PubMed ID: 19244253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of diabetic neuropathy by regulatable expression of HSV-mediated erythropoietin.
    Wu Z; Mata M; Fink DJ
    Mol Ther; 2011 Feb; 19(2):310-7. PubMed ID: 20924361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Herpes simplex virus mediated nerve growth factor expression in bladder and afferent neurons: potential treatment for diabetic bladder dysfunction.
    Goins WF; Yoshimura N; Phelan MW; Yokoyama T; Fraser MO; Ozawa H; Bennett N JR; de Groat WC; Glorioso JC; Chancellor MB
    J Urol; 2001 May; 165(5):1748-54. PubMed ID: 11342969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of Herpes Simplex Virus Vector Encoding the Human Preproenkephalin Gene for Treatment of Facial Pain in Mice.
    Ma F; Wang C; Yoder WE; Westlund KN; Carlson CR; Miller CS; Danaher RJ
    J Oral Facial Pain Headache; 2016; 30(1):42-50. PubMed ID: 26817032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A human trial of HSV-mediated gene transfer for the treatment of chronic pain.
    Wolfe D; Mata M; Fink DJ
    Gene Ther; 2009 Apr; 16(4):455-60. PubMed ID: 19242524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene therapy for bladder overactivity and nociception with herpes simplex virus vectors expressing preproenkephalin.
    Yokoyama H; Sasaki K; Franks ME; Goins WF; Goss JR; de Groat WC; Glorioso JC; Chancellor MB; Yoshimura N
    Hum Gene Ther; 2009 Jan; 20(1):63-71. PubMed ID: 20377371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HSV-mediated gene transfer of the glial cell-derived neurotrophic factor provides an antiallodynic effect on neuropathic pain.
    Hao S; Mata M; Wolfe D; Huang S; Glorioso JC; Fink DJ
    Mol Ther; 2003 Sep; 8(3):367-75. PubMed ID: 12946309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Viral vector mediated continuous expression of interleukin-10 in DRG alleviates pain in type 1 diabetic animals.
    Thakur V; Gonzalez M; Pennington K; Chattopadhyay M
    Mol Cell Neurosci; 2016 Apr; 72():46-53. PubMed ID: 26802537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.